COPD Patients’ Needs and Current Treatment Options

COPD Patients’ Needs and Current Treatment Options

October 24, 2014 at 10:15 AM 0 comments

Summary of Presentations from a Novartis-Supported Satellite Symposium, held at the 24th ERS Congress, Munich, Germany, on 8th September 2014 Chairperson: Bartolome Celli1 Speakers: Donald Tashkin,2 Claus Vogelmeier,3 Jadwiga Wedzicha4 1. Professor of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA 2. Emeritus Professor of Medicine, David Geffen School ofRead More

Nocturnal Non-Invasive Ventilation for Chronic Obstructive Pulmonary Disease: A Final Breakthrough?

Nocturnal Non-Invasive Ventilation for Chronic Obstructive Pulmonary Disease: A Final Breakthrough?

October 24, 2014 at 10:09 AM 0 comments

Summary of Presentations from a ResMed-Sponsored Satellite Symposium, held at the 24th ERS Congress, Munich, Germany, on 8th September 2014 Chairperson: Wolfram Windisch1 Speakers: Jean-Louis Pepin,2 Thomas Köhnlein,3 Michael Dreher4 1. Cologne Merheim Medical Centre, Cologne, Germany 2. Hopital CHR Citadelle, Liege, Belgium 3. St. Georg Unternehmensgruppe, Leipzig, Germany 4.Read More

New Evidence and Novel Therapies for Severe Asthma Management

New Evidence and Novel Therapies for Severe Asthma Management

October 24, 2014 at 10:04 AM 0 comments

*Caroline Charles Scilink Medical Writing *Correspondence to scilink.mw@gmail.com Disclosure: Medical writing assistance was funded by Novartis. Received: 16.09.14 Accepted: 14.10.14 Citation: EMJ Respir. 2014;2:50-57. Abstract The 2014 European Respiratory Society International Congress, held last month from 6th-10th September in Munich, Germany, provided a platform for key opinion leaders in theRead More

New Options for Optimal Bronchodilation in Chronic Obstructive Pulmonary Disease

New Options for Optimal Bronchodilation in Chronic Obstructive Pulmonary Disease

October 24, 2014 at 10:00 AM 0 comments

*Caroline Charles Scilink Medical Writing *Correspondence to scilink.mw@gmail.com Disclosure: Medical writing assistance was funded by Novartis. Received: 15.09.14 Accepted: 08.10.14 Citation: EMJ Respir. 2014;2:58-66. Abstract The European Respiratory Society (ERS) International Congress was held in Munich, Germany, on 6th- 10th September 2014, and was a particularly important opportunity for leadingRead More

Event-Driven Studies and Serious Chronic Diseases: Addressing Placebo, Drug Efficacy, and Treatment Failure in Pulmonary Artery Hypertension

Event-Driven Studies and Serious Chronic Diseases: Addressing Placebo, Drug Efficacy, and Treatment Failure in Pulmonary Artery Hypertension

October 24, 2014 at 9:55 AM 0 comments

Henning Gall,1 Paul Corris2 1. University of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands 2. Department of Respiratory Medicine, Institute of Transplantation and Institute of Cellular Medicine, Newcastle University, and the Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne,Read More

Rationale for Endobronchial Coil Treatment as the Primary Intervention for Patients with Severe Emphysema

Rationale for Endobronchial Coil Treatment as the Primary Intervention for Patients with Severe Emphysema

October 24, 2014 at 9:49 AM 0 comments

*Hans Klose,1 H. Jost Achenbach2 1. University Medical Center Hamburg-Eppendorf, Hamburg, Germany 2. Lostau Lung Clinic, Centre for Pneumology and Thoracic Surgery, Lostau, Germany *Correspondence to klose@uke.de Disclosure: H.K. has received speaker fees and honoraria from PneumRx, and acts as a consultant to the company. H.J.A. has received travel supportRead More

Novel Insights Into Chronic Obstructive Pulmonary Disease (COPD): An Overview

Novel Insights Into Chronic Obstructive Pulmonary Disease (COPD): An Overview

October 24, 2014 at 9:43 AM 0 comments

*Sukhwinder Singh Sohal, Mathew Suji Eapen, Shakti Dhar Shukla, Jo-Maree Courtney, Malik Quasir Mahmood, Eugene Haydn Walters Breathe Well Centre of Research Excellence for Chronic Respiratory Disease and Lung Ageing, School of Medicine, University of Tasmania, Tasmania, Australia *Correspondence to sssohal@utas.edu.au Disclosure: The authors declare no competing financial interests. Received:Read More

Inhaled Ambient Particulate Matter and Lung Health Burden

Inhaled Ambient Particulate Matter and Lung Health Burden

October 24, 2014 at 9:36 AM 0 comments

Swapna Upadhyay,1 Koustav Ganguly,2 *Tobias Stoeger3 1. Department of Biotechnology, Indian Institute of Technology Madras, Chennai, India 2. SRM Research Institute, SRM University, Chennai, India 3. Institute of Lung Biology and Disease, Comprehensive Pneumology Centre, Helmholtz Zentrum Munich, German Research Centre for Environmental Health, Munich, Germany *Correspondence to tobias.stoeger@helmholtz-muenchen.de Disclosure:Read More

Influence of Air Pollution on Respiratory Disease

Influence of Air Pollution on Respiratory Disease

October 24, 2014 at 9:25 AM 0 comments

*Frank J. Kelly MRC-PHE Centre for Environment and Health and NIHR Health Protection Research Unit in Environmental Hazards, King’s College, London, UK *Correspondence to frank.kelly@kcl.ac.uk Disclosure: The author’s research was funded in part by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Health Impact ofRead More

Brief Clinical Review: Non-Responding Pneumonia

Brief Clinical Review: Non-Responding Pneumonia

October 24, 2014 at 9:18 AM 0 comments

Simon Finch, *James D. Chalmers Tayside Respiratory Research Group, University of Dundee and Ninewells Hospital and Medical School, Dundee, Scotland *Correspondence to jchalmers@dundee.ac.uk Disclosure: No potential conflict of interest. Received: 05.05.14 Accepted: 24.07.14 Citation: EMJ Respir. 2014;2:104-111. Abstract A slowly resolving or non-resolving pneumonia (NRP) is a common clinical dilemma,Read More